Fundamental Analysis · Last Quarter

FA

A dedicated fundamental analysis might help you to get a quick overview of the financial stability. However it is important to understand the FA Algorithm and the criterias before valuing it as a solution.

See FA Rationale
Framework:
Valuation Weak
28%
Profitability n.A.
Fin. Growth Balanced
50%
Leverage & Liquidity Weak
17%
Per Share Metrics Positive
67%
Fin. Health n.A.
Fundamentals

Valuation

Metric Q1 Q2 Δ in %
EV/EBITDA -16.35 21.98 26.28
Graham Fair Price 32.19 15017.19 11359.93
PEG 507.93 0.12 -0.02
Price/Book -4.22 1.31 1.37
Price/Cash Flow -64.42 47.50 -133.51
Prices/Earnings -39.97 8.27 13.77
Price/Sales -6.40 2.18 2.33
Price/FCF -64.42 47.50 -133.51
Naive Interpretation member
01 - Valuation · Weak
Fundamentals

Profitability

Metric Q1 Q2 Δ in %
Gross Profit Margin 5.48 0.46 0.44
Operating Margin 31.10 0.10 0.08
ROA 61.92 0.01 < 0.005
ROE 0.02 0.04 59.54
ROIC 0.02 0.02 47.60
Naive Interpretation member
02 - Profitability · Not Interpreted
Fundamentals

Financial Growth

Metric Q1 Q2 Δ in %
Debt QOQ < 0.005 < 0.005 -3647.78
Dividends QOQ 0.00 0.00 0.00
EBIT QOQ 0.60 0.40 -32.65
EPS QOQ 6.78 0.67 -90.12
FCF QOQ -1.49 3.82 155.76
Revenue QOQ < 0.005 0.07 11468.87
Naive Interpretation member
03 - Financial Growth · Balanced
Fundamentals

Leverage & Liquidity

Metric Q1 Q2 Δ in %
Assets Turnover n.A. n.A. n.A.
Days Inventory Outstanding (DIO) 65.84 72.50 10.13
Days Sales Outstanding (DSO) 53.22 58.17 9.29
Inventory Turnover 1.37 1.24 -9.20
Debt/Capitalization 0.48 0.47 -2.46
Quick Ratio 0.43 0.48 13.26
Naive Interpretation member
04 - Leverage & Liquidity · Weak
Fundamentals

Per Share Metrics

Metric Q1 Q2 Δ in %
Book Value 15191.38 16217.92 6.76
Cash 4237.09 3793.54 -10.47
Capex -336.46 820.58 143.89
Free Cash Flow -155.80 438.95 181.74
Revenue 8932.96 9567.04 7.10
Naive Interpretation member
05 - Per Share Metrics · Positive
Fundamentals

Financial Health

Metric Q1 Q2 Δ in %
Current Ratio 0.65 0.66 1.09
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 9.40 8.25 -12.23
Naive Interpretation Member
06 - Financial Health · Bad
Rating